Hopes of a treatment for the coronavirus powered one S&P 500 biotech company more than 3% higher as global stock markets plunged.
The post Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge appeared first on CCN.com
Read the original post: Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge
